We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

69 hedge funds and large institutions have $65.2M invested in abrdn Life Sciences Investors in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 16

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

1.18% more ownership

Funds ownership: 17.94% → 19.12% (+1.2%)

0% more funds holding

Funds holding: 69 → 69 (0)

8% less capital invested

Capital invested by funds: $71.2M → $65.2M (-$5.97M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
69
Holders Change
–
Holders Change %
0%
% of All Funds
1.52%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
12
Increased
30
Reduced
16
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MC
Matisse Capital
Oregon
+$3.18M
2
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$2.6M
3
AAM
Advisors Asset Management
Colorado
+$1.3M
4
CRC
Curi RMB Capital
Illinois
+$1.28M
5
1CP
1607 Capital Partners
Virginia
+$1.2M

Top Sellers

Rank Fund Capital Flow
1
CA
Cornerstone Advisors
North Carolina
-$3.05M
2
MIG
Mariner Investment Group
New York
-$1.93M
3
LCM
Landscape Capital Management
New Jersey
-$1.43M
4
WAM
Wolverine Asset Management
Illinois
-$524K
5
RJA
Raymond James & Associates
Florida
-$348K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$487K -$25.6K -1,561 -5%
Walleye Capital
27
Walleye Capital
New York
$483K +$124K +7,600 +31%
GC
28
Guggenheim Capital
Illinois
$460K +$109K +6,654 +28%
MAFM
29
Mid Atlantic Financial Management
Pennsylvania
$442K +$67.1K +4,100 +16%
AA
30
AQR Arbitrage
Connecticut
$433K +$264K +16,124 +126%
Lido Advisors
31
Lido Advisors
California
$397K – – –
OC
32
Oppenheimer & Co
New York
$380K +$26.9K +1,640 +7%
Ameriprise
33
Ameriprise
Minnesota
$369K -$62.1K -3,790 -13%
First Trust Advisors
34
First Trust Advisors
Illinois
$345K -$44.2K -2,700 -11%
NFG
35
Next Financial Group
Texas
$327K +$51.9K +3,169 +17%
TFCP
36
Twin Focus Capital Partners
Massachusetts
$327K +$357K +21,800 New
Stifel Financial
37
Stifel Financial
Missouri
$313K +$53.5K +3,267 +18%
AUB
38
Atlantic Union Bankshares
Virginia
$311K -$4.91K -300 -1%
Citigroup
39
Citigroup
New York
$310K +$111K +6,805 +49%
Goldman Sachs
40
Goldman Sachs
New York
$290K +$317K +19,365 New
SKK
41
Shepherd Kaplan Krochuk
Massachusetts
$277K +$30.3K +1,850 +11%
SFS
42
Shaker Financial Services
Virginia
$240K +$263K +16,036 New
PIA
43
Powell Investment Advisors
Florida
$221K – – –
Walleye Trading
44
Walleye Trading
New York
$213K +$26.2K +1,600 +13%
DA
45
Doliver Advisors
Texas
$212K -$241K -14,734 -55%
MIAN
46
Mariner Independent Advisor Network
Kansas
$210K +$3.06K +187 +1%
WEC
47
Winslow Evans & Crocker
Massachusetts
$192K +$6.39K +390 +3%
YCM
48
Yakira Capital Management
Connecticut
$187K +$205K +12,500 New
QCIG
49
Quad-Cities Investment Group
Iowa
$158K +$5.22K +319 +3%
JMPWA
50
JP Morgan Private Wealth Advisors
California
$151K +$165K +10,049 New
1
2
3

HQL Hedge Fund Activity: Q1 2020 in Review

69 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2020, worth a combined $65.2M — down 8.4% from $71.2M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new HQL positions and 10 closed out — a net gain of 2 holders — while 30 added to existing stakes and 16 trimmed.

The largest buyer was Matisse Capital, opening a new position worth an estimated $3.18M. The largest seller was Cornerstone Advisors, exiting entirely with an estimated $3.05M sold.

  • 69 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $65.2M of abrdn Life Sciences Investors stock for Q1 2020, down 8.4% quarter-over-quarter.
  • 12 funds opened new abrdn Life Sciences Investors positions in Q1 2020 and 10 closed out, a net change of +2 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2020 was Matisse Capital, an estimated $3.18M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2020 was Cornerstone Advisors, an estimated $3.05M sold.

Based on aggregated 13F filings for Q1 2020.